Back
Brookfield Renewable Partners LP Vs. Keros Therapeutics Industry Stock Comparison
Buy
69
BEP
Brookfield Renewable Partners LP
Last Price:
28.30
Seasonality Move:
0.78%
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
Buy
69
Brookfield Renewable Partners LP (BEP)
is a Buy
Is Brookfield Renewable Partners LP a Buy, Sell or Hold?
- The current Brookfield Renewable Partners LP [BEP] share price is $27.96. The Score for BEP is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- BEP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.92. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BEP Stock Price Chart
What is Brookfield Renewable Partners LP's stock price today?
-
The Brookfield Renewable Partners LP share price today is $27.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEP is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
BEP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.75 | Buy |
| Relative Strength Index (14 RSI): | 74.13 | Buy |
| Chaikin Money Flow: | 317038 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.35 - 26.73) | Buy |
| Bollinger Bands (100): | (24.32 - 27.12) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.17 | Buy |
| Relative Strength Index (14 RSI): | 64.2 | Buy |
| Chaikin Money Flow: | -162874 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.46 - 56.8) | Buy |
| Bollinger Bands (100): | (45.02 - 53.82) | Buy |
BEP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.89 | Buy |
| 20-day SMA: | 25.78 | Buy |
| 50-day SMA: | 24.91 | Buy |
| 200-day SMA: | 24.87 | Buy |
| 8-day EMA: | 27 | Buy |
| 20-day EMA: | 26.13 | Buy |
| 50-day EMA: | 25.45 | Buy |
| 200-day EMA: | 25.23 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.92 | Buy |
| 20-day SMA: | 53.86 | Buy |
| 50-day SMA: | 50.03 | Buy |
| 200-day SMA: | 52.7 | Buy |
| 8-day EMA: | 55.87 | Buy |
| 20-day EMA: | 53.93 | Buy |
| 50-day EMA: | 51.33 | Buy |
| 200-day EMA: | 49.85 | Buy |
Brookfield Renewable Partners LP Earnings Growth & BEP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.49 per share, and an increase next year of $0.50 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
Brookfield Renewable Partners LP Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||